Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Arbutus Biopharma

ABUS

ABUS Arbutus Biopharma NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Options
    Financials
    News
    Filings
    Profile
    ABUS Chart
    See on advanced chart >
    All
    D
    W
    M
    5m
    • Volume 629.58k
    • Turnover 2.14M
    • P/E(TTM) --
    • Turnover % 0.43%
    • P/E(Static) --
    • Market Cap 648.06M
    • P/B 6.06
    • Shares 189.49M
    • 52 Week Range
      2.210
      4.725
    • Day Range
      3.285
      3.445

    About

    Arbutus Biopharma Corporation was incorporated the British Columbia on October 6, 2005. The company is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms...
    • Highlight
      A clinical-stage biopharmaceutical company that developing therapeutics for hepatitis B virus
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      11/15/2010
    • Established Date
      10/06/2005
    • Full-time Employees
      73
    • Address
      701 Veterans Circle Warminster PA 18974
    • Tel
      1-267-4690914
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App
    All
    QUICK
    Daily
    Weekly
    Monthly
    Minutes
    5 minutes
    15 minutes
    30 minutes
    Ranges
    1 Day
    1 Week
    1 Month
    1 Year
    YTD